# Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.

> **NCT07242534** · PHASE4 · RECRUITING · sponsor: **Fundacion Dexeus** · enrollment: 62 (estimated)

## Conditions studied

- Infertility
- Obesity

## Interventions

- **DRUG:** Semaglutide
- **OTHER:** No pre-treatment

## Key facts

- **NCT ID:** NCT07242534
- **Lead sponsor:** Fundacion Dexeus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-19
- **Primary completion:** 2027-02
- **Final completion:** 2027-05
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07242534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07242534, "Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.". Retrieved via AI Analytics 2026-05-18 from https://api.ai-analytics.org/clinical/NCT07242534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*